Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma 1Non-alcoholic Fatty Liver Disease 1Lymphoma 1Hypertension 1Hematologic Neoplasms 1Dyspnea 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

relacorilant 2pazopanib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fimasartan 1cediranib 1benazepril 1Surveys and Questionnaires 1Sulindac 1Ramipril 1Observation 1Losartan 1Lisinopril 1Interviews as Topic 1Hydrochlorothiazide 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hypertension × Lisinopril × Clear all
NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Wake Forest University Health Sciences

Phase 2 Terminated
6 enrolled 10 charts

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡